Significant Ownership of Ikarian Capital, LLC

Signature - Title
/s/ Neil Shahrestani - Neil Shahrestani, Sole Manager
Location
Dallas, TX
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by Ikarian Capital, LLC.

Notify me when Ikarian Capital, LLC files a new Schedule 13D/G report.

⭐ Subscribe ⭐

Significant Ownership of Ikarian Capital, LLC

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
QNRX Quoin Pharmaceuticals, Ltd. American Depositary Shares, each representing thirty-five (35) Ordinary Shares, no par value per share 25% $4,383,067 211,538 Ikarian Capital, LLC 30 Nov 2025
GLTO Galecto, Inc. Common Stock, $0.00001 par value per share 22% 285,710 Ikarian Capital, LLC 30 Nov 2025
TENX Tenax Therapeutics, Inc. Common Stock, $0.0001 par value per share 16% $6,473,244 967,600 0% Ikarian Capital, LLC 30 Nov 2025
SPRB Spruce Biosciences Inc. Common Stock, par value $0.0001 per share 11% $1,082,872 121,356 0% Ikarian Capital, LLC 31 Oct 2025
TRAW Traws Pharma, Inc. Common stock, par value $.01 per share 10% $1,161,319 +$384,637 589,502 +50% Ikarian Capital, LLC 31 Mar 2025
GRTX Galera Therapeutics, Inc. Common Stock, $0.001 par value per share 10% $376,934 7,538,690 Ikarian Capital, LLC 31 Dec 2024
CHRO Channel Therapeutics Corp Common Stock, par value $0.0001 per share 7.3% $595,146 440,849 Ikarian Capital, LLC 31 Dec 2024
ATXI Avenue Therapeutics, Inc. Common Stock 6.8% $46,200 140,000 Ikarian Capital, LLC 31 Dec 2024
PTHS Pelthos Therapeutics Inc. Common Stock, par value $0.0001 per share 6.1% $6,300,590 186,408 Ikarian Capital, LLC 30 Sep 2025
ACOG Alpha Cognition Inc. Common Shares, no par value 6% $4,287,651 967,867 Ikarian Capital, LLC 31 Dec 2024
FBRX Forte Biosciences, Inc. Common Stock, $0.001 par value 5% $7,059,934 +$96,492 617,667 +1.4% Ikarian Capital, LLC 30 Jun 2025
IBIO IBIO, Inc. Common Stock 5% $918,654 1,151,051 Ikarian Capital, LLC 30 Sep 2025
CPIX Cumberland Pharmaceuticals Inc. Common Stock, no par value 4.9% $3,091,842 730,932 Ikarian Capital, LLC 31 Mar 2025
RLMD Relmada Therapeutics, Inc. Common Stock, par value $0.001 par value per share 4.8% $7,122,152 3,543,359 Ikarian Capital, LLC 30 Sep 2025
AVTX Avalo Therapeutics, Inc. Common Stock, $0.001 Par Value 3.8% $9,049,101 -$6,100,673 711,967 -40% Ikarian Capital, LLC 30 Sep 2025
AEMD Aethlon Medical, Inc. Common Stock, $0.001 par value per share 2% $6,300 -$497,707 15,366 -99% Ikarian Capital, LLC 30 Sep 2025

Schedules 13D/G Reported by Ikarian Capital, LLC:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Filing Date
* An asterisk sign (*) next to the price indicates that the price is likely invalid.